INDUSTRY TRENDS

Curetis to Launch Multiplex MDx for Hospital Infections in U.S.

Molecular diagnostics firm Curetis (Germany) specializes in solutions to rapidly diagnose and profile antibiotic resistance for severe infections in hospitalized patients. The company currently has … [Read more...]

NEWS

Testing Guidelines at a Glance

The American Society of Clinical Oncology (ASCO) published updated practice guidelines Aug. 14 in the Journal of Clinical Oncology regarding the use of targeted immunotherapy for patients with stage … [Read more...]

NEWS

Inside the Diagnostics Industry: At-Home Testing Options Expanding

There is a proliferation of companies offering at-home testing. In some cases these are mail-in tests where patients collect their own samples (blood, mouth swab, urine, or stool) and mail them into a … [Read more...]

INDUSTRY TRENDS

Genomic Testing May Be Currently Overhyped, Oncologists Say

Most oncologists believe genomic testing is a major advance, but that it is "significantly overpromoted," according to a survey conducted by Medscape and the Swedish Cancer Institute in … [Read more...]

GENETIC TESTING

Genome Medical Bridges Genomic Testing, Medical Practice

Lisa Alderson, co-founder and CEO, Genome Medical Many well-known barriers are slowing the integration of genomic testing into routine clinical practice, including workforce shortages and a lack … [Read more...]

RESEARCH

iSpecimen Generates New Market for Discarded Biospecimens

iSpecimen (Lexington, Mass.) can be thought of as a cross between a dating site and an online marketplace for human biospecimens. The company has built a turnkey solution that connects providers, such … [Read more...]

RESEARCH

iSpecimen Creates Marketplace for Clinical Discards

iSpecimen (Lexington, Mass.) can be thought of as a cross between a dating site and an online marketplace for human biospecimens. The company has built a turnkey solution that connects providers, such … [Read more...]

PRECISION MEDICINE

Guidelines Suggest Standardized Interpretation and Reporting of Somatic Sequence Variants

A common refrain within the diagnostics industry is a need for standardization. Rapidly developing technology and testing methods, the call for interoperability, and the vast amount of data and … [Read more...]

REIMBURSEMENT

Inside The Diagnostics Industry: Medicare Coverage of Molecular Tests Continues to Evolve

Advanced diagnostic tests are emerging faster than the clinicians can document their clinical utility. All of this creates an interesting dilemma for payors as far as coverage is concerned. Normally … [Read more...]

PRECISION MEDICINE

New Guidelines Suggest Tiered Approach to Standardize Interpretation and Reporting of Sequence Variants in Cancer

Aconstant refrain within the diagnostics industry is a need for standardization. Rapidly developing technology and testing methods, the call for interoperability, and the vast amount of data and … [Read more...]


(-0000g2)